Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment decisions. Read why PFE stock is a Hold.

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

But the long term shareholders of Pfizer Inc. (NYSE ... has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During the three ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has ...

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

With trade war volatility off the charts, investors are hunting for safety in safe dividend stocks. That’s because dividend ...

Pharmaceutical stocks tumble as Trump announces imminent “major tariff” on imported drugs. Pfizer, Merck, and Johnson & Johnson shares drop over 4%, dragging the broader S&P 500 lower.

Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE: PFE) into terminating the development of its weight-loss ...

ANKARA (Reuters) -Turkey on Friday began administering Pfizer (NYSE:PFE) and BioNTech's COVID-19 shots, introducing a second ...